AI-generated summary
This randomized clinical trial of 30 patients with community-acquired pneumonia compared photobiomodulation (940-nm LED vest) plus conventional therapy with conventional therapy alone over 7 days. The authors report improved oxygen saturation, lung function and shorter hospital stay in the LED group, with no differences in the control group stated in the abstract.
- Participants
- 30
- Who or what was studied
- Patients with community-acquired pneumonia (CAP)
- Wavelengths
- 940 nm
- Limits stated in the abstract
- The abstract describes a small single-trial sample of 30 patients, and does not state the certainty of the findings or report the control group's results for comparison.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Light-emitting diode, Control group, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.